Earlier: Securities Of Kazia Therapeutics Will Be Suspended From Quotation Immediately Under Listing Rule 17.2, At The Request Of KZA, To Facilitate Its Removal From The Official List Of ASX Limited
Portfolio Pulse from Charles Gross
Kazia Therapeutics' securities will be suspended from quotation immediately under ASX Listing Rule 17.2, at the company's request, to facilitate its removal from the ASX Official List.

November 13, 2023 | 9:39 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Kazia Therapeutics has requested the suspension of its securities from quotation to proceed with its delisting from the ASX.
The suspension of Kazia Therapeutics' securities is a significant step towards its delisting from the ASX, which could indicate a strategic shift or other corporate actions that may affect investor confidence and the stock's liquidity. This typically has a negative short-term impact on a company's stock price as it may raise concerns among investors about the reasons behind the delisting and the future of the company.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100